Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2008-08-01

Clinical Trial Update: Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

View source ↗

Summary

This clinical trial update reports withdrawal of antifungal treatment for histoplasmosis in patients who showed improved immune response to antiretroviral thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Histoplasmosis | Status: COMPLETED